New drug D-2570 tested for safety in first human study
NCT ID NCT07270783
First seen Jun 26, 2026 · Last updated Jul 15, 2026 · Updated 3 times
Summary
This early-phase trial is testing the safety and tolerability of a new drug called D-2570 in 36 healthy volunteers. Participants receive either the drug or a placebo, and researchers monitor side effects and how the drug moves through the body. Since this is a Phase 1 study in healthy people, there is no direct treatment benefit.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- D-2570
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pharmaron
Baltimore, Maryland, 21201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?